BRKR on Nasdaq

Bruker

Logo: Guigui2306, CC BY-SA 4.0, via Wikimedia Commons4

American scientific instrument manufacturer

Bruker Corporation is an American manufacturer of scientific instruments for molecular and materials research, as well as for industrial and applied analysis. It is headquartered in Billerica, Massachusetts, and is the publicly traded parent company of Bruker Scientific Instruments (Bruker AXS, Bruker BioSpin, Bruker Daltonics and Bruker Optics) and Bruker Energy & Supercon Technologies (BEST) divisions.3 From Wikipedia, CC BY-SA 4.0

Price unavailable

Last updated Oct 16, 2026.

Overview

$3.4BRevenue, fiscal 20255
-$8.6MNet income, fiscal 20255
1960Founded1

Compare with Waters Corporation, Mettler Toledo or Revvity Inc., or pick any stock.

  • TickerBRKR on Nasdaq1
  • IndustryLaboratory Analytical Instruments1
  • HeadquartersBillerica1
  • Websitewww.bruker.com
  • Legal formDelaware corporation1
  • Incorporated inDE6
  • Business address40 Manning Rd, Billerica, Ma 018216
  • Filer categoryLarge accelerated filer6

Bruker Corporation is an American manufacturer of scientific instruments for molecular and materials research, as well as for industrial and applied analysis. It is headquartered in Billerica, Massachusetts, and is the publicly traded parent company of Bruker Scientific Instruments (Bruker AXS, Bruker BioSpin, Bruker Daltonics and Bruker Optics) and Bruker Energy & Supercon Technologies (BEST) divisions.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

45.9%Gross margin5
2.0%Operating margin5
-0.3%Net margin5
2.1%Revenue growth, 20255
-0.4%Return on equity5
0.75×Debt to equity5
$43.3MFree cash flow5

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Product brought in 81% of the revenue Bruker broke down this way in fiscal 2025.

  1. Product$2.8B581%up 0% from 2024
  2. Product and Service, Other$670.1M519%up 10% from 2024
Products and services by year
Products and services202320242025
Product$2.5B$2.8B$2.8B
Product and Service, Other$506.9M$607.2M$670.1M

Business segments

Bsi Calid brought in 35% of the revenue Bruker broke down this way in fiscal 2025.

  1. Bsi Calid$1.2B535%up 11% from 2024
  2. Bsi Nano$1.1B531%down 1% from 2024
  3. BSI BioSpin$878.8M526%down 3% from 2024
  4. Energy And Supercon Technologies$270.9M58%down 4% from 2024
Business segments by year
Business segments202320242025
Bsi Calid$960.4M$1.1B$1.2B
Bsi Nano$941.9M$1.1B$1.1B
BSI BioSpin$798.5M$905.7M$878.8M
Energy And Supercon Technologies$280.7M$283.0M$270.9M

Regions

Europe, Excluding Germany brought in 28% of the revenue Bruker broke down this way in fiscal 2025.

  1. Europe, Excluding Germany$950.2M528%up 9% from 2024
  2. United States$891.3M526%down 5% from 2024
  3. Asia Pacific Excluding China$552.6M516%up 7% from 2024
  4. China$475.8M514%up 1% from 2024
  5. Germany$297.0M59%down 4% from 2024
  6. Other Country$269.6M58%up 6% from 2024
Regions by year
Regions202320242025
Europe, Excluding Germany$699.7M$873.0M$950.2M
United States$777.7M$938.5M$891.3M
Asia Pacific Excluding China$460.9M$518.5M$552.6M
China$528.1M$471.2M$475.8M
Germany$281.5M$310.7M$297.0M
Other Country$216.6M$254.5M$269.6M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue54¢$1.9B
  • Research and development12¢$395.2M
  • Selling, general and admin28¢$946.5M
  • Other costs6¢$206.7M
  • Income tax1¢$29.3M

Out of $3.4B in revenue.5 The company lost money this year.

Where each dollar of operating cash went, fiscal 2025

  • Capital spending68¢$90.8M
  • Dividends paid17¢$22.8M
  • Share buybacks7¢$10.0M
  • Kept or used elsewhere8¢$10.5M

Out of $134.1M of cash from operations.5

Financial statements

Revenue891011125$3.4B in 2025+81% since 2018
0$1.0B$2.0B$3.0B$4.0B2018: $1.9B$1.9B20182019: $2.1B$2.1B2019+9%2020: $2.0B$2.0B2020−4%2021: $2.4B$2.4B2021+22%2022: $2.5B$2.5B2022+5%2023: $3.0B$3.0B2023+17%2024: $3.4B$3.4B2024+14%2025: $3.4B$3.4B2025+2%
Gross profit891011125$1.6B in 2025+75% since 2018
0$500.0M$1.0B$1.5B$2.0B2018: $900.0M$900.0M20182019: $995.3M$995.3M2019+11%2020: $939.8M$939.8M2020−6%2021: $1.2B$1.2B2021+29%2022: $1.3B$1.3B2022+8%2023: $1.5B$1.5B2023+16%2024: $1.6B$1.6B2024+9%2025: $1.6B$1.6B2025−4%
Operating income891011125$68.2M in 2025−74% since 2018
0$200.0M$400.0M$600.0M2018: $262.4M$262.4M20182019: $300.9M$300.9M2019+15%2020: $248.3M$248.3M2020−17%2021: $413.3M$413.3M2021+66%2022: $432.7M$432.7M2022+5%2023: $436.9M$436.9M2023+1%2024: $253.1M$253.1M2024−42%2025: $68.2M$68.2M2025−73%
Net income891011125-$8.6M in 2025
-$200.0M0$200.0M$400.0M$600.0M2018: $179.7M$179.7M20182019: $197.2M$197.2M2019+10%2020: $157.8M$157.8M2020−20%2021: $277.1M$277.1M2021+76%2022: $296.6M$296.6M2022+7%2023: $427.2M$427.2M2023+44%2024: $113.1M$113.1M2024−74%2025: -$8.6M-$8.6M2025

Every line of the income statement in the latest annual report, as filed.5

Period ending2025-12-312024-12-312023-12-31
Total revenue$3.4B$3.4B$3.0B
Total cost of revenue$1.9B$1.7B$1.5B
Gross profit$1.6B$1.6B$1.5B
Selling, general and administrative$946.5M$893.8M$729.4M
Research and development$395.2M$376.5M$294.8M
Goodwill impairment charge$96.5M$0$0
Other charges, net$71.3M$126.1M$52.2M
Total operating expenses$1.5B$1.4B$1.1B
Operating income$68.2M$253.1M$436.9M
Bargain purchase gain and associated measurement period adjustments$0-$8.0M$144.1M
Interest and other expense, net-$46.2M-$38.2M-$36.8M
Income before income taxes, equity in (losses) income of unconsolidated investees, net of tax, and noncontrolling interests in consolidated subsidiaries$22.0M$206.9M$544.2M
Income tax provision$29.3M$91.4M$117.7M
Equity in (losses) income of unconsolidated investees, net of tax-$1.0M-$1.7M$2.0M
Consolidated net (loss) income-$8.3M$113.8M$428.5M
Net income attributable to noncontrolling interests in consolidated subsidiaries$300.0K$700.0K$1.3M
Net (loss) income attributable to Bruker Corporation-$8.6M$113.1M$427.2M
Dividends on Series A Mandatory Convertible Preferred Stock$13.9M$0$0
Net (loss) income attributable to Bruker Corporation common shareholders-$22.5M$113.1M$427.2M
Basic-$0.15$0.76$2.92
Diluted-$0.15$0.76$2.90
Basic151.8M shares149.0M shares146.4M shares
Diluted151.8M shares149.5M shares147.2M shares

Compare Bruker with another company

The story

Founded by Günther Laukien in 1960.1

The company was founded on September 7, 1960, in Karlsruhe, Germany as Bruker-Physik AG by five people, one of them being Günther Laukien, who was a professor at the University of Karlsruhe at the time. The name Bruker originates from co-founder Emil Bruker, as Günther Laukien himself was formally not allowed to commercialize his research whilst being a professor. Bruker produced Nuclear Magnetic Resonance Spectroscopy (NMR) and EMR spectroscopy equipment then.

In the early 1960s, the company had around 60 employees and was growing rapidly. One of the early success products was the HFX 90 NMR spectroscopy system, with three independent channels and which was also the first NMR system using only semiconductor transistors.

In 1969, Bruker launched the first commercial Fourier transform NMR spectroscopy system (FT-NMR) and in the 1970s the company was the first to commercialize a superconducting FT-NMR. Later, the company would expand their product range with MRI, FTIR and FT-Raman spectrometers and with mass spectrometers.

In 1968, Bruker shipped NMR systems to Yale University in Connecticut. After that, demand from the US grew, so Bruker opened an office in Elmsford, New York which marked the start of their US activities. In 2008 after a corporate reorganization lasting 8 years, all divisions were merged in a unified Bruker Corporation.

Günther Laukien died in 1997; one of his four sons Frank Laukien, is currently the CEO of Bruker. Another son, Jörg C. Laukien, also works for the company. Another son, Dirk D. Laukien, is a former company executive.

From Wikipedia’s article on Bruker, shared under CC BY-SA 4.0.7

Leadership

Who has led Bruker, and when. Pick a name to see everywhere that person has worked.

Products and brands

Bruker develops and delivers a wide variety of professional and scientific analysis devices including mass spectrometers, single-Crystal and powder X-ray diffractometers, X-ray tomography devices, NMR spectroscopy devices, fluorescence microscopes, raman spectroscopes, atomic-force microscopes, and profilometers.

Notable product use

Bruker products are used globally in a variety of situations. The National High Magnetic Field Laboratory at Florida State University selected Bruker to build the world's first 21.0 tesla FT-ICR MS.

The Total Carbon Column Observing Network uses high resolution FT-IR spectrometers made by Bruker to measure various greenhouse gases across the globe.

From Wikipedia’s article on Bruker, shared under CC BY-SA 4.0.7

Subsidiaries and ownership

Subsidiaries

  • Bruker (Canada)
  • Bruker (France)
  • Bruker (Israel)
  • Bruker (Switzerland)
  • Bruker (United States)

From Wikidata.1

Acquisitions

Bruker acquisitions include GE NMR Instruments (1992), Siemens AXS (1997), Nonius (2001), MacScience (2002), Vacuumschmelze Hanau (2003), Röntec (2005), SOCABIM (2005), PGT (2005), Keymaster (2006), Quantron (2006), JuWe (2008), SIS (2008), ACCEL (2009), Michrom Bioresources (2011), Skyscan (2012), Prairie Technologies (2013), Oncovision (Preclinical PET imaging business, 2016), Oxford Instruments Superconducting Technology (2016), Hysitron Inc. (2017), XGLab (2017), Luxendo (2017), JPK Instruments (2018), Alicona (2018), PMOD Technologies LLC (2019), Canopy Biosciences (2020), Optimal Group (2022), Neurescence Inc (2022), PhenomeX (2023), MIRO Analytical (majority 2023), NanoString Technologies assets (2024), and ELITechGroup (2024).

Other

In 1964, the company bought the NMR division of the Swiss Trüb-Täuber. Bruker made several offers to take over its supplier Oxford Instruments during the 1970s, but after almost a decade of negotiations, an acquisition was eventually rejected by Oxford Instruments. In 1997, the analytical X-ray division of Siemens was acquired by Bruker. In 2010, Bruker bought 3 product lines from Agilent, which Agilent had acquired from Varian. These included mass spectrometry and gas chromatography instruments. They have since divested these products to Scion Instruments with the exception of the triple quadrupole In 2012, Bruker bought parts of Carestream Health, including their in-vivo imaging portfolio and related aspects.

In 2019, Bruker bought Alicona, known for production of metrology equipment based on focus variation, to extend its analytics business in the industrial market. In 2020, Bruker acquired Canopy Biosciences. This acquisition allowed Canopy to leverage Bruker's global infrastructure and expertise in product design and engineering. The financial terms of the deal were not disclosed. In November 2022, it was announced Bruker had acquired the Mountain View-headquartered miniaturized microscope / miniscope company, Inscopix, Inc.

From Wikipedia’s article on Bruker, shared under CC BY-SA 4.0.7

Former names

  • BRUKER BIOSCIENCES CORPJul 24, 2003 to Feb 27, 20086
  • BRUKER DALTONICS INCJun 20, 2000 to Jul 2, 20036

Timeline

  1. 1960Founded Founded1

Recent filings

  1. Sep 16, 20264
  2. Sep 15, 2026144
  3. Aug 18, 20264
  4. Aug 18, 20264
  5. Aug 18, 20264
  6. Aug 18, 20264
  7. Aug 18, 20264
  8. Aug 18, 20264
  9. Aug 18, 20264
  10. Aug 17, 2026144
  11. Aug 14, 20268-K
  12. Aug 14, 2026144
  13. Aug 13, 20264
  14. Aug 13, 20264
  15. Aug 13, 20264

Every filing from the last three years, summarized. The full record is on SEC EDGAR.2